AstraZeneca’s Zurampic Received Green Signal from US FDA
The U.S. FDA on 23rd Dec 2015 accepted Zurampic (lesinurad) to treat higher levels of uric acid in the blood
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine